BACKGROUND: Prior epidemiological work has shown higher mortality in ischemic stroke patients admitted on weekends, which has been termed the 'weekend effect'. Our aim was to assess stroke patient outcomes in order to determine the significance of the 'weekend effect' at 2 comprehensive stroke centers. METHODS: Consecutive stroke patients were identified using prospective databases. Patients were categorized into 4 groups: intracerebral hemorrhage (ICH group), ischemic strokes not treated with IV t-PA (intravenous tissue plasminogen activator; IS group), acute ischemic strokes treated with IV t-PA (AIS-TPA group), and transient ischemic attack (TIA group). Weekend admission was defined as the period from Friday, 17:01, to Monday, 08:59. Patients treated beyond the 3-hour window, receiving intra-arterial therapy, or enrolled in nonobservational clinical trials were excluded. Patient demographics, NIHSS scores, and admission glucose levels were examined. Adverse events, poor functional outcome (modified Rankin scale, mRS, 3-6), and mortality were compared. RESULTS: A total of 2,211 patients were included (1,407 site 1, 804 site 2). Thirty-six percent (800/2,211) arrived on a weekend. No significant differences were found in the ICH, IS, AIS-TPA, or TIA groups with respect to the rate of symptomatic ICH, mRS on discharge, discharge disposition, 90-day mRS, or 90-day mortality when comparing weekend and weekday groups. Using multivariate logistic regression to adjust for site, age, admission NIHSS, and blood glucose, weekend admission was not a significant independent predictive factor for in-hospital mortality in all strokes (OR = 1.10, 95% CI 0.74-1.63, p = 0.631). CONCLUSIONS: Our results suggest that comprehensive stroke centers (CSC) may ameliorate the 'weekend effect' in stroke patients. These results may be due to 24/7 availability of stroke specialists, advanced neuroimaging, or ongoing training and surveillance of specialized nursing care available at CSC. While encouraging, these results require confirmation in prospective studies. Copyright (c) 2008 S. Karger AG, Basel.
BACKGROUND: Prior epidemiological work has shown higher mortality in ischemic strokepatients admitted on weekends, which has been termed the 'weekend effect'. Our aim was to assess strokepatient outcomes in order to determine the significance of the 'weekend effect' at 2 comprehensive stroke centers. METHODS: Consecutive strokepatients were identified using prospective databases. Patients were categorized into 4 groups: intracerebral hemorrhage (ICH group), ischemic strokes not treated with IV t-PA (intravenous tissue plasminogen activator; IS group), acute ischemic strokes treated with IV t-PA (AIS-TPA group), and transient ischemic attack (TIA group). Weekend admission was defined as the period from Friday, 17:01, to Monday, 08:59. Patients treated beyond the 3-hour window, receiving intra-arterial therapy, or enrolled in nonobservational clinical trials were excluded. Patient demographics, NIHSS scores, and admission glucose levels were examined. Adverse events, poor functional outcome (modified Rankin scale, mRS, 3-6), and mortality were compared. RESULTS: A total of 2,211 patients were included (1,407 site 1, 804 site 2). Thirty-six percent (800/2,211) arrived on a weekend. No significant differences were found in the ICH, IS, AIS-TPA, or TIA groups with respect to the rate of symptomatic ICH, mRS on discharge, discharge disposition, 90-day mRS, or 90-day mortality when comparing weekend and weekday groups. Using multivariate logistic regression to adjust for site, age, admission NIHSS, and blood glucose, weekend admission was not a significant independent predictive factor for in-hospital mortality in all strokes (OR = 1.10, 95% CI 0.74-1.63, p = 0.631). CONCLUSIONS: Our results suggest that comprehensive stroke centers (CSC) may ameliorate the 'weekend effect' in strokepatients. These results may be due to 24/7 availability of stroke specialists, advanced neuroimaging, or ongoing training and surveillance of specialized nursing care available at CSC. While encouraging, these results require confirmation in prospective studies. Copyright (c) 2008 S. Karger AG, Basel.
Authors: Mark J Alberts; Richard E Latchaw; Warren R Selman; Timothy Shephard; Mark N Hadley; Lawrence M Brass; Walter Koroshetz; John R Marler; John Booss; Richard D Zorowitz; Janet B Croft; Ellen Magnis; Diane Mulligan; Andrew Jagoda; Robert O'Connor; C Michael Cawley; J J Connors; Jean A Rose-DeRenzy; Marian Emr; Margo Warren; Michael D Walker Journal: Stroke Date: 2005-06-16 Impact factor: 7.914
Authors: William J Kostis; Kitaw Demissie; Stephen W Marcella; Yu-Hsuan Shao; Alan C Wilson; Abel E Moreyra Journal: N Engl J Med Date: 2007-03-15 Impact factor: 91.245
Authors: Achint A Patel; Abhimanyu Mahajan; Alexandre Benjo; Ambarish Pathak; Jitesh Kar; Vishal B Jani; Narender Annapureddy; Shiv Kumar Agarwal; Manpreet S Sabharwal; Priya K Simoes; Ioannis Konstantinidis; Rabi Yacoub; Fahad Javed; Georges El Hayek; Madhav C Menon; Girish N Nadkarni Journal: Neurohospitalist Date: 2015-09-03
Authors: Guilherme B F Porto; Alejandro M Spiotta; Julio A Chalela; Ryan T Kellogg; Edward C Jauch Journal: Neurocrit Care Date: 2015-12 Impact factor: 3.210
Authors: Ingrid V Rodríguez-Rivera; Fernando Santiago; Estela S Estapé; Lorena González-Sepúlveda; Ricardo Brau Journal: P R Health Sci J Date: 2015-09 Impact factor: 0.705
Authors: Kelvin L Chou; Jorge Zamudio; Peter Schmidt; Catherine C Price; Sotirios A Parashos; Bastiaan R Bloem; Kelly E Lyons; Chadwick W Christine; Rajesh Pahwa; Ivan Bodis-Wollner; Wolfgang H Oertel; Oksana Suchowersky; Michael J Aminoff; Irene A Malaty; Joseph H Friedman; Michael S Okun Journal: Parkinsonism Relat Disord Date: 2011-04-01 Impact factor: 4.891
Authors: Karen C Albright; Sean I Savitz; Rema Raman; Sheryl Martin-Schild; Joseph Broderick; Karin Ernstrom; Andria Ford; Rakesh Khatri; Dawn Kleindorfer; David Liebeskind; Randolph Marshall; José G Merino; Dawn M Meyer; Natalia Rost; Brett C Meyer Journal: Cerebrovasc Dis Date: 2012-12-01 Impact factor: 2.762
Authors: William C Johnson; Nicolas A Morton-Gonzaba; John V Lacci; Daniel Godoy; Alireza Mirahmadizadeh; Ali Seifi Journal: Neurocrit Care Date: 2019-04 Impact factor: 3.210